Robert B Howe

Summary

Affiliation: University of Minnesota

Country: USA

The WHO classification of MDS does make a difference
Robert B Howe
Division of Hematology, Oncology and Transplantation, University of Minnesota, Mayo Mail Code 480, 420 Delaware St SE, Minneapolis, MN 55455, USA
Blood 103:3265-70. 2004
Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients
Milena Elimelakh
Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA
Haematologica 92:1029-36. 2007
Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations
Ramin Tehranchi
Department of Medicine, Division of Hematology, Karolinska University Hospital, Karolinska Institutet, Huddinge, Stockholm, Sweden
Clin Cancer Res 11:6291-9. 2005

The WHO classification of MDS does make a difference
Robert B Howe
Division of Hematology, Oncology and Transplantation, University of Minnesota, Mayo Mail Code 480, 420 Delaware St SE, Minneapolis, MN 55455, USA
Blood 103:3265-70. 2004
..5 months; P =.03)...
Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients
Milena Elimelakh
Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA
Haematologica 92:1029-36. 2007
..We report a high incidence of RCA and autoimmune hemolytic anemia (AIHA) in pancreas transplant recipients on alemtuzumab-based maintenance therapy...
Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations
Ramin Tehranchi
Department of Medicine, Division of Hematology, Karolinska University Hospital, Karolinska Institutet, Huddinge, Stockholm, Sweden
Clin Cancer Res 11:6291-9. 2005
....